Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Phase 1 immune system diseases biotech Attovia Therapeutics files for a $100 million IPO

Attovia Therapeutics logo

Attovia Therapeutics, a Phase 1 biotech developing biotherapeutics for immune-mediated diseases, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. Attovia Therapeutics is a clinical-stage biopharmaceutical company...read more

JonesTrading's SPAC Jones Ventures INTL Acquisition1 prices $200 million IPO

Jones Ventures INTL Acquisition1, a blank check company backed by JonesTrading, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share at the time of the business...read more

IPO Winners & Losers: SK hynix, Mega IPOs, and Hidden Volatility

Welcome back to Renaissance Capital’s IPO Winners and Losers, the weekly podcast breaking down the biggest stories shaping the IPO market. Click here to get the newsletter in your inbox every week.

...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.